Unlock instant, AI-driven research and patent intelligence for your innovation.

Entecavir intermediate and preparation method thereof

A technology for entecavir and intermediates, which is applied in the field of entecavir intermediates and their preparation, can solve the problems of being unsuitable for industrialized production, difficult to obtain, and low in product yield.

Active Publication Date: 2017-10-13
HSING PHARMACEUTICALS CO LTD
View PDF34 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The technical problem to be solved by the present invention is to overcome the relatively expensive reaction raw materials of the existing entecavir preparation method, difficult to obtain, harsh reaction conditions, low product yield, cumbersome post-processing operations, low atom utilization, serious environmental pollution and unsuitable for industrialization. Production and other defects, but provide entecavir intermediates and preparation methods thereof

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Entecavir intermediate and preparation method thereof
  • Entecavir intermediate and preparation method thereof
  • Entecavir intermediate and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0155]

[0156] Example 1-1 is in compound 2 (R1 is ) (30.1g, 86.5mmol) in water (6500mL) were added potassium bicarbonate (260g, 2600mmol), potassium fluoride (100g, 1720mmol). 30% hydrogen peroxide (550 g, 4320 mmol) was slowly added to the obtained mixed solution at 70 degrees Celsius. After the dropwise addition, the mixed solution was incubated at 70 degrees Celsius and stirred for 3 hours, then added acetic acid (1150 mL), and continued to be incubated at 70 degrees Celsius and stirred for 30 minutes. The mixture was filtered through diatomaceous earth and then slowly cooled to 5°C. The powdered crystals collected by filtration were washed with distilled water at 5°C, redispersed in 2500mL of distilled water, and heated to 95°C to dissolve them completely. The resulting supernatant was slowly cooled to 5°C. The obtained powdery crystals were collected by filtration and dried to obtain 121.3 g of the desired target compound, with a yield of 89%.

[0157] 1 H NMR ...

Embodiment 2

[0164]

Embodiment 2-1

[0166] Compound 3-1 (R 2 for P 2 To a solution of benzyl) (82.0 g, 165 mmol) in dichloromethane (82 mL) was added concentrated sulfuric acid (8.2 mL, 98%). The resulting brown liquid was stirred at 25°C for 2 hours and then slowly dropped into an aqueous potassium hydroxide solution (2M, 1.6L). After the obtained mixed solution was evaporated to dryness of the organic solvent, acetic acid was added to adjust the pH=6-7. The solid obtained is collected by filtration and dried to obtain the desired target compound 2-1 (R 1 for ) 50g, yield 87%.

[0167] 1 H NMR (400MHz, CDCl 3 ): δ7.64(s, 1H), 5.30(s, 2H), 5.16-5.10(m, 1H), 3.88-3.72(m, 2H), 3.56-3.46(m, 1H), 2.52-2.38(m , 1H), 2.17-1.92(m, 2H), 1.90-1.75(m, 1H), 1.73-1.54(m, 4H), 1.00-0.70(m, 4H);

[0168] 13 C NMR (100MHz, CD 3 OD): δ159.4, 155.2, 153.9, 153.1, 129.1, 117.4, 112.1, 63.2, 59.7, 44.1, 30.1, 19.5, 17.1, 8.6,

[0169] ESI-MS: 348.1[M+H] + .

[0170] Example 2-2 to Example 2-8 were prepared accordin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an entecavir intermediate and a preparation method thereof. The present invention provides a method for preparing an entecavir intermediate compound 3, which comprises the following steps: performing a reduction reaction on compound 4 in a solvent to obtain compound 3. The present invention also provides a method for preparing an entecavir intermediate compound 4, which comprises the following steps: performing an acetal exchange reaction between compound 5 and compound 18 in a solvent under acidic conditions to obtain compound 4. The preparation method of the invention has cheap and easy-to-obtain raw materials, mild reaction conditions and high product yield. The atomic economy is good, the environment is friendly, and it is suitable for industrial production.

Description

technical field [0001] The invention relates to an entecavir intermediate and a preparation method thereof. Background technique [0002] As an important class of compounds, nucleotide analogues have received extensive attention in the field of medicinal chemistry. Research related to it has produced a large number of important drugs, especially in the field of antiviral drugs. A considerable number of anti-AIDS drugs and anti-hepatitis B drugs have benefited from in-depth research in this field. [0003] There are 350 million to 400 million hepatitis B virus (HBV) infected people in the world, and nearly 1 million patients die of liver cirrhosis and liver cancer caused by HBV infection every year. There are more than 120 million HBV infections in my country, accounting for more than 1 / 3 of the world's total, ranking first in the world, and 30 million patients with chronic hepatitis B (hepatitis B), and this number is currently on the rise. Chronic hepatitis B virus infec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F7/10C07D473/18
Inventor 应律陈清泉胡俊斌
Owner HSING PHARMACEUTICALS CO LTD